Robyn Elliott

Dr Elliott is Executive Director, Strategic Fractionation Program Delivery within the Global Network Strategy team CSL Behring, a subsidiary of CSL Limited (ASX:CSL). Her role is responsible for business value delivery from a billion dollar global capital expansion portfolio. She is also a non-executive director of PolyNovo Limited (ASX:PNV).

Dr Elliott’s 9 years at CSL Behring have included Senior Director roles for Strategic Expansion Projects and Quality, including supporting the global network strategy team determining the ten-year expansion plan for the CSL Behring global business. Prior to CSL Behring she was Managing Director at IDT Australia Ltd (ASX:IDT) and commenced her career at DBL Faulding.

Dr Elliott has a proven track record in product development, clinical trials, regulatory affairs, audits, quality management, project management and operational strategy. Her worldwide experience in new facility delivery, production scale up, strategic planning and governance will be of significant benefit to Proteomics International as it drives expansion of its commercial operations.